APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Gastrointestinal Therapeutics and Diagnostics

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Gastrointestinal Therapeutics and Diagnostics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173994280321 December 2025185 pages

Choose your research edition.

Industry ResearchGastrointestinal Therapeutics and Diagnostics Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Gastrointestinal Therapeutics and Diagnostics Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Gastrointestinal Therapeutics and Diagnostics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gastrointestinal Therapeutics and Diagnostics Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Gastrointestinal Therapeutics and Diagnostics Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Gastrointestinal Therapeutics and Diagnostics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Gastrointestinal Therapeutics and Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gastrointestinal Therapeutics and Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gastrointestinal Therapeutics and Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Gastrointestinal Therapeutics and Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Gastrointestinal Therapeutics and Diagnostics include Takeda Pharmaceutical Company, Eisai, Johnson & Johnson, AstraZeneca, Salix Pharmaceuticals and Abbott Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Gastrointestinal Therapeutics and Diagnostics market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gastrointestinal Therapeutics and Diagnostics and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gastrointestinal Therapeutics and Diagnostics revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Gastrointestinal Therapeutics and Diagnostics market size, projected growth trends, production technologies, key applications, and end-use industries.

Gastrointestinal Therapeutics and Diagnostics Segment by Company

Takeda Pharmaceutical Company

Eisai

Johnson & Johnson

AstraZeneca

Salix Pharmaceuticals

Abbott Laboratories

Gastrointestinal Therapeutics and Diagnostics Segment by Type

Diagnostics

Therapeutics

Gastrointestinal Therapeutics and Diagnostics Segment by Application

Peptic Ulcer Disease (PUD)

GI Bleeding

Gastroenteritis

Irritable Bowel Syndrome

Others

Gastrointestinal Therapeutics and Diagnostics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gastrointestinal Therapeutics and Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gastrointestinal Therapeutics and Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gastrointestinal Therapeutics and Diagnostics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Gastrointestinal Therapeutics and Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gastrointestinal Therapeutics and Diagnostics industry.

Chapter 3: Detailed analysis of Gastrointestinal Therapeutics and Diagnostics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gastrointestinal Therapeutics and Diagnosticsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Diagnostics Table 3. Key Players of Therapeutics Table 4. Global Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Peptic Ulcer Disease (PUD) Table 6. Key Players of GI Bleeding Table 7. Key Players of Gastroenteritis Table 8. Key Players of Irritable Bowel Syndrome Table 9. Key Players of Others Table 10. Global Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Region (2021-2026) Table 13. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Region (2027-2032) Table 15. Gastrointestinal Therapeutics and Diagnostics Industry Trends Table 16. Gastrointestinal Therapeutics and Diagnostics Industry Drivers Table 17. Gastrointestinal Therapeutics and Diagnostics Industry Opportunities and Challenges Table 18. Gastrointestinal Therapeutics and Diagnostics Industry Restraints Table 19. Global Gastrointestinal Therapeutics and Diagnostics Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Company (2021-2026) Table 21. Global Gastrointestinal Therapeutics and Diagnostics Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Gastrointestinal Therapeutics and Diagnostics Key Company Head Office and Area Served Table 23. Global Gastrointestinal Therapeutics and Diagnostics Company, Product Type & Application Table 24. Global Gastrointestinal Therapeutics and Diagnostics Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Gastrointestinal Therapeutics and Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Type (2021-2026) Table 31. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Type (2027-2032) Table 32. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Application (2021-2026) Table 36. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Application (2027-2032) Table 37. Takeda Pharmaceutical Company Company Information Table 38. Takeda Pharmaceutical Company Business Overview Table 39. Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Product Portfolio Table 41. Takeda Pharmaceutical Company Recent Development Table 42. Eisai Company Information Table 43. Eisai Business Overview Table 44. Eisai Gastrointestinal Therapeutics and Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Eisai Gastrointestinal Therapeutics and Diagnostics Product Portfolio Table 46. Eisai Recent Development Table 47. Johnson & Johnson Company Information Table 48. Johnson & Johnson Business Overview Table 49. Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Product Portfolio Table 51. Johnson & Johnson Recent Development Table 52. AstraZeneca Company Information Table 53. AstraZeneca Business Overview Table 54. AstraZeneca Gastrointestinal Therapeutics and Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. AstraZeneca Gastrointestinal Therapeutics and Diagnostics Product Portfolio Table 56. AstraZeneca Recent Development Table 57. Salix Pharmaceuticals Company Information Table 58. Salix Pharmaceuticals Business Overview Table 59. Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Product Portfolio Table 61. Salix Pharmaceuticals Recent Development Table 62. Abbott Laboratories Company Information Table 63. Abbott Laboratories Business Overview Table 64. Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Product Portfolio Table 66. Abbott Laboratories Recent Development Table 67. North America Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 68. North America Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 69. North America Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 70. North America Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 71. North America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 72. North America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2021-2026) Table 73. North America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2027-2032) Table 74. Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 75. Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 76. Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 77. Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 78. Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 79. Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2021-2026) Table 80. Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2027-2032) Table 81. China Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 82. China Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 83. China Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 84. China Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 85. Asia Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 86. Asia Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 87. Asia Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 88. Asia Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 89. Asia Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. Asia Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2021-2026) Table 91. Asia Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2027-2032) Table 92. South America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 93. South America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 94. South America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 95. South America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 96. South America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. South America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2021-2026) Table 98. South America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2027-2032) Table 99. Research Programs/Design for This Report Table 100. Authors List of This Report Table 101. Secondary Sources Table 102. Primary Sources List of Figures Figure 1. Gastrointestinal Therapeutics and Diagnostics Product Image Figure 2. Global Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Type: 2025 VS 2032 Figure 4. Diagnostics Image Figure 5. Therapeutics Image Figure 6. Global Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Application: 2025 VS 2032 Figure 8. Peptic Ulcer Disease (PUD) Image Figure 9. GI Bleeding Image Figure 10. Gastroenteritis Image Figure 11. Irritable Bowel Syndrome Image Figure 12. Others Image Figure 13. Global Gastrointestinal Therapeutics and Diagnostics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Gastrointestinal Therapeutics and Diagnostics Market Size (2021-2032) & (US$ Million) Figure 15. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Gastrointestinal Therapeutics and Diagnostics Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Type (2021-2032) Figure 22. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Application (2021-2032) Figure 24. North America Gastrointestinal Therapeutics and Diagnostics Market Size (2021-2032) & (US$ Million) Figure 25. North America Gastrointestinal Therapeutics and Diagnostics Market Share by Type (2021-2032) Figure 26. North America Gastrointestinal Therapeutics and Diagnostics Market Share by Application (2021-2032) Figure 27. North America Gastrointestinal Therapeutics and Diagnostics Market Share by Country (2021-2032) Figure 28. United States Gastrointestinal Therapeutics and Diagnostics Market Size (2021-2032) & (US$ Million) Figure 29. Canada Gastrointestinal Therapeutics and Diagnostics Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Gastrointestinal Therapeutics and Diagnostics Market Size (2021-2032) & (US$ Million) Figure 31. Europe Gastrointestinal Therapeutics and Diagnostics Market Size (2021-2032) & (US$ Million) Figure 32. Europe Gastrointestinal Therapeutics and Diagnostics Market Share by Type (2021-2032) Figure 33. Europe Gastrointestinal Therapeutics and Diagnostics Market Share by Application (2021-2032) Figure 34. Europe Gastrointestinal Therapeutics and Diagnostics Market Share by Country (2021-2032) Figure 35. Germany Gastrointestinal Therapeutics and Diagnostics Market Size (2021-2032) & (US$ Million) Figure 36. France Gastrointestinal Therapeutics and Diagnostics Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Gastrointestinal Therapeutics and Diagnostics Market Size (2021-2032) & (US$ Million) Figure 38. Italy Gastrointestinal Therapeutics and Diagnostics Market Size (2021-2032) & (US$ Million) Figure 39. Russia Gastrointestinal Therapeutics and Diagnostics Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Gastrointestinal Therapeutics and Diagnostics Market Size (2021-2032) & (US$ Million) Figure 41. China Gastrointestinal Therapeutics and Diagnostics Market Size (2021-2032) & (US$ Million) Figure 42. China Gastrointestinal Therapeutics and Diagnostics Market Share by Type (2021-2032) Figure 43. China Gastrointestinal Therapeutics and Diagnostics Market Share by Application (2021-2032) Figure 44. Asia Gastrointestinal Therapeutics and Diagnostics Market Size (2021-2032) & (US$ Million) Figure 45. Asia Gastrointestinal Therapeutics and Diagnostics Market Share by Type (2021-2032) Figure 46. Asia Gastrointestinal Therapeutics and Diagnostics Market Share by Application (2021-2032) Figure 47. Asia Gastrointestinal Therapeutics and Diagnostics Market Share by Country (2021-2032) Figure 48. Japan Gastrointestinal Therapeutics and Diagnostics Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Gastrointestinal Therapeutics and Diagnostics Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Gastrointestinal Therapeutics and Diagnostics Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Gastrointestinal Therapeutics and Diagnostics Market Size (2021-2032) & (US$ Million) Figure 52. India Gastrointestinal Therapeutics and Diagnostics Market Size (2021-2032) & (US$ Million) Figure 53. Australia Gastrointestinal Therapeutics and Diagnostics Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Share by Country (2021-2032) Figure 58. Brazil Gastrointestinal Therapeutics and Diagnostics Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Gastrointestinal Therapeutics and Diagnostics Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Gastrointestinal Therapeutics and Diagnostics Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Gastrointestinal Therapeutics and Diagnostics Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Gastrointestinal Therapeutics and Diagnostics Market Size (2021-2032) & (US$ Million) Figure 63. UAE Gastrointestinal Therapeutics and Diagnostics Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Gastrointestinal Therapeutics and Diagnostics Market Size (2021-2032) & (US$ Million) Figure 65. Chile Gastrointestinal Therapeutics and Diagnostics Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Diagnostics
  • Therapeutics
Applications
  • Peptic Ulcer Disease (PUD)
  • GI Bleeding
  • Gastroenteritis
  • Irritable Bowel Syndrome
  • Others
Companies covered
  • Takeda Pharmaceutical Company
  • Eisai
  • Johnson & Johnson
  • AstraZeneca
  • Salix Pharmaceuticals
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Diagnostics
  5. 1.2.3 Therapeutics
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Peptic Ulcer Disease (PUD)
  9. 1.3.3 GI Bleeding
  10. 1.3.4 Gastroenteritis
  11. 1.3.5 Irritable Bowel Syndrome
  12. 1.3.6 Others
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Gastrointestinal Therapeutics and Diagnostics Growth Trends by Region
  15. 1.5.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2021-2026)
  17. 1.5.3 Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Gastrointestinal Therapeutics and Diagnostics Market Dynamics
  1. 2.1 Gastrointestinal Therapeutics and Diagnostics Industry Trends
  2. 2.2 Gastrointestinal Therapeutics and Diagnostics Industry Drivers
  3. 2.3 Gastrointestinal Therapeutics and Diagnostics Industry Opportunities and Challenges
  4. 2.4 Gastrointestinal Therapeutics and Diagnostics Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Gastrointestinal Therapeutics and Diagnostics Revenue by Company (2021-2026)
  2. 3.2 Global Gastrointestinal Therapeutics and Diagnostics Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Gastrointestinal Therapeutics and Diagnostics Key Company Head office and Area Served
  4. 3.4 Global Gastrointestinal Therapeutics and Diagnostics Company, Product Type & Application
  5. 3.5 Global Gastrointestinal Therapeutics and Diagnostics Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Gastrointestinal Therapeutics and Diagnostics Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Gastrointestinal Therapeutics and Diagnostics Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Gastrointestinal Therapeutics and Diagnostics Tier 1, Tier 2, and Tier 3
4 Gastrointestinal Therapeutics and Diagnostics Market by Type
  1. 4.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2021-2032)
  3. 4.3 Global Gastrointestinal Therapeutics and Diagnostics Market Size Share by Type (2021-2032)
5 Gastrointestinal Therapeutics and Diagnostics Market by Application
  1. 5.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2021-2032)
  3. 5.3 Global Gastrointestinal Therapeutics and Diagnostics Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Takeda Pharmaceutical Company
  2. 6.1.1 Takeda Pharmaceutical Company Company Information
  3. 6.1.2 Takeda Pharmaceutical Company Business Overview
  4. 6.1.3 Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Product Portfolio
  6. 6.1.5 Takeda Pharmaceutical Company Recent Developments
  7. 6.2 Eisai
  8. 6.2.1 Eisai Company Information
  9. 6.2.2 Eisai Business Overview
  10. 6.2.3 Eisai Gastrointestinal Therapeutics and Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Eisai Gastrointestinal Therapeutics and Diagnostics Product Portfolio
  12. 6.2.5 Eisai Recent Developments
  13. 6.3 Johnson & Johnson
  14. 6.3.1 Johnson & Johnson Company Information
  15. 6.3.2 Johnson & Johnson Business Overview
  16. 6.3.3 Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Product Portfolio
  18. 6.3.5 Johnson & Johnson Recent Developments
  19. 6.4 AstraZeneca
  20. 6.4.1 AstraZeneca Company Information
  21. 6.4.2 AstraZeneca Business Overview
  22. 6.4.3 AstraZeneca Gastrointestinal Therapeutics and Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 AstraZeneca Gastrointestinal Therapeutics and Diagnostics Product Portfolio
  24. 6.4.5 AstraZeneca Recent Developments
  25. 6.5 Salix Pharmaceuticals
  26. 6.5.1 Salix Pharmaceuticals Company Information
  27. 6.5.2 Salix Pharmaceuticals Business Overview
  28. 6.5.3 Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Product Portfolio
  30. 6.5.5 Salix Pharmaceuticals Recent Developments
  31. 6.6 Abbott Laboratories
  32. 6.6.1 Abbott Laboratories Company Information
  33. 6.6.2 Abbott Laboratories Business Overview
  34. 6.6.3 Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Product Portfolio
  36. 6.6.5 Abbott Laboratories Recent Developments
7 North America
  1. 7.1 North America Gastrointestinal Therapeutics and Diagnostics Market Size (2021-2032)
  2. 7.2 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Type
  3. 7.2.1 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2021-2026)
  4. 7.2.2 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2027-2032)
  5. 7.2.3 North America Gastrointestinal Therapeutics and Diagnostics Market Share by Type (2021-2032)
  6. 7.3 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Application
  7. 7.3.1 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2021-2026)
  8. 7.3.2 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2027-2032)
  9. 7.3.3 North America Gastrointestinal Therapeutics and Diagnostics Market Share by Application (2021-2032)
  10. 7.4 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Country
  11. 7.4.1 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2021-2026)
  13. 7.4.3 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2027-2032)
  14. 7.4.4 North America Gastrointestinal Therapeutics and Diagnostics Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Gastrointestinal Therapeutics and Diagnostics Market Size (2021-2032)
  2. 8.2 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Type
  3. 8.2.1 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2021-2026)
  4. 8.2.2 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2027-2032)
  5. 8.2.3 Europe Gastrointestinal Therapeutics and Diagnostics Market Share by Type (2021-2032)
  6. 8.3 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Application
  7. 8.3.1 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2021-2026)
  8. 8.3.2 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2027-2032)
  9. 8.3.3 Europe Gastrointestinal Therapeutics and Diagnostics Market Share by Application (2021-2032)
  10. 8.4 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Country
  11. 8.4.1 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2021-2026)
  13. 8.4.3 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2027-2032)
  14. 8.4.4 Europe Gastrointestinal Therapeutics and Diagnostics Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Gastrointestinal Therapeutics and Diagnostics Market Size (2021-2032)
  2. 9.2 China Gastrointestinal Therapeutics and Diagnostics Market Size by Type
  3. 9.2.1 China Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2021-2026)
  4. 9.2.2 China Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2027-2032)
  5. 9.2.3 China Gastrointestinal Therapeutics and Diagnostics Market Share by Type (2021-2032)
  6. 9.3 China Gastrointestinal Therapeutics and Diagnostics Market Size by Application
  7. 9.3.1 China Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2021-2026)
  8. 9.3.2 China Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2027-2032)
  9. 9.3.3 China Gastrointestinal Therapeutics and Diagnostics Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Gastrointestinal Therapeutics and Diagnostics Market Size (2021-2032)
  2. 10.2 Asia Gastrointestinal Therapeutics and Diagnostics Market Size by Type
  3. 10.2.1 Asia Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2021-2026)
  4. 10.2.2 Asia Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2027-2032)
  5. 10.2.3 Asia Gastrointestinal Therapeutics and Diagnostics Market Share by Type (2021-2032)
  6. 10.3 Asia Gastrointestinal Therapeutics and Diagnostics Market Size by Application
  7. 10.3.1 Asia Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2021-2026)
  8. 10.3.2 Asia Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2027-2032)
  9. 10.3.3 Asia Gastrointestinal Therapeutics and Diagnostics Market Share by Application (2021-2032)
  10. 10.4 Asia Gastrointestinal Therapeutics and Diagnostics Market Size by Country
  11. 10.4.1 Asia Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2021-2026)
  13. 10.4.3 Asia Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2027-2032)
  14. 10.4.4 Asia Gastrointestinal Therapeutics and Diagnostics Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst